External Control Arm Builder with Bias Audit
Constructs RWD-based external comparators with transparent cohort design and bias diagnostics Evidence basis: FDA externally controlled trial guidance describes key validity threats and fit-for-purpose expectations; oncology emulation studies show EHR-derived cohorts can approximate some control arms with sensitivity to cohort construction choices
The Problem
“Build transparent external control arms from real-world data with auditable bias diagnostics”
Organizations face these key challenges:
Eligibility criteria and outcomes are frequently buried in free-text clinical notes
Cohort construction choices materially change treatment effect estimates
Bias diagnostics are inconsistent across studies and reviewers
Regulatory teams need transparent fit-for-purpose justification for data and methods
Manual evidence review and chart abstraction are slow and expensive
Missingness, coding variation, and temporal alignment issues complicate target trial emulation
Impact When Solved
The Shift
Human Does
- •Define external comparator objectives and eligibility criteria manually
- •Review available real-world data sources and document assumptions
- •Assemble cohorts with spreadsheet-based tracking and cross-checks
- •Conduct retrospective bias review and sensitivity discussions
Automation
- •No AI-driven analysis in the legacy workflow
- •No automated cohort screening or prioritization
- •No continuous bias monitoring or alerting
Human Does
- •Approve cohort design choices and fit-for-purpose assumptions
- •Review bias findings and decide on sensitivity analyses
- •Resolve exceptions, data ambiguities, and protocol deviations
AI Handles
- •Screen candidate records against cohort criteria and flag gaps
- •Generate transparent cohort construction summaries and decision logs
- •Assess bias risks across key design choices and surface diagnostics
- •Prioritize cases needing expert review based on validity concerns
Operating Intelligence
How External Control Arm Builder with Bias Audit runs once it is live
AI runs the first three steps autonomously.
Humans own every decision.
The system gets smarter each cycle.
Who is in control at each step
Each column marks the operating owner for that step. AI-led actions sit above the divider, human decisions and feedback loops sit below it.
Step 1
Assemble Context
Step 2
Analyze
Step 3
Recommend
Step 4
Human Decision
Step 5
Execute
Step 6
Feedback
AI lead
Autonomous execution
Human lead
Approval, override, feedback
AI handles assembly, analysis, and execution. The human gate sits at the decision point. Every cycle refines future recommendations.
The Loop
6 steps
Assemble Context
Combine the relevant records, signals, and constraints.
Analyze
Evaluate options, risk, and likely outcomes.
Recommend
Present a ranked recommendation with supporting rationale.
Human Decision
A human accepts, edits, or rejects the recommendation.
Authority gates · 1
The application must not finalize an external comparator cohort without approval from the clinical study lead or epidemiology lead [S2][S3].
Why this step is human
The decision carries real-world consequences that require professional judgment and accountability.
Execute
Carry out the approved action in the operating workflow.
Feedback
Outcome data improves future recommendations.
1 operating angles mapped
Operational Depth
Technologies
Technologies commonly used in External Control Arm Builder with Bias Audit implementations:
Key Players
Companies actively working on External Control Arm Builder with Bias Audit solutions:
Real-World Use Cases
NLP-assisted extraction of unstructured EHR variables for target trial eligibility and outcomes
Teach software to read doctors’ notes so hidden patient details can be used to decide who qualifies for an emulated trial and what happened to them.
AI-supported regulatory assessment of external control evidence quality
Use AI tools to check whether outside patient data is good enough and similar enough to fairly compare against a new drug study.